HyperliquidvsArcus
Stock and index perps two ways: Hyperliquid’s builder markets on its own L1 versus Arcus on Robinhood Chain, still waitlisted and without a published audit.
At a glance
Full comparison
Every figure is a dated snapshot from public sources (Oct 10, 2026); fields without a verifiable source show n/a. “Best” marks the stronger value in a row — higher volume or liquidity, lower fees, longer track record. Max leverage is shown as information, not a positive.
| Exchange | $HYPE ★★★★★★★★★★91/100Excellent | $— ★★★★★★★★★★70/100Fair |
|---|---|---|
| Type | Perp DEX | Perp + Spot (RWA) |
| Chains | Hyperliquid L1 | Robinhood Chain |
| 24h volume | $2.52BBest | $282.6M |
| 7d volume | $34.33BBest | $3.16B |
| Total value lockedLiquidity depth | $7.11BBest | $50.4M |
| Open interest | $11.96BBest | $88.0M |
| Token price | $84.23 | No token |
| 24h change | 0.98% | — |
| Market cap | $18.74B | n/a |
| Maker feeNegative = rebate | 0.015% | 0%Best |
| Taker feeLower is cheaper | 0.045% | 0.0225%Best |
| Max leverageHigher = riskier | 40× | 50× |
| Trading pairs | 178Best | 60 |
| LaunchedLonger track record | 2024Best | 2026 |
| Security scoredexwatch estimate | 88/100 | n/a |
| Audits | Zellic (bridge) | Not available |
Matching runs off-chain; custody and settlement are on-chain with an escape hatch for withdrawals. Perps are still rolled out by waitlist and are not available in the US, UK or Canada. No public audit report was found, and reported volume is about ten times open interest.
Affiliate links are marked and may earn dexwatch a commission at no extra cost to you. Educational content only — not financial advice.
Want a different matchup?
Open this in the live tool and add up to four DEXes.
The honest take
We have not published an editorial pros-and-cons review for Arcus yet; the figures above come from public sources.